Motility News

Cannabinoid hyperemesis syndrome is a condition experienced by chronic marijuana users who develop symptoms like nausea, vomiting and abdominal pain, which are characteristically relieved by hot showers.

Perrigo has launched a new, orally disintegrating omeprazole tablet for the treatment of frequent heartburn.

“Both gastric acid-suppressive medications and antibiotics have been implicated as factors that may enhance the development of allergic diseases,” Edward Mitre, MD, from the department of microbiology and immunology at the F. Edward Hébert School of Medicine in the Uniformed Services University of the Health Sciences, and colleagues wrote. “Use of these medications, which can directly cause intestinal dysbiosis, is of concern in light of increasing evidence that alterations in the human microbiome can increase the risk for allergy development.”

High-volume colon irrigation can be an effective and safe alternative to medical therapy for patients with chronic constipation, according to research published in the Journal of Clinical Gastroenterology and Hepatology.

The use of proton pump inhibitors over a long period did not increase the risk for hip fracture in patients with Alzheimer’s disease, according to new research published in Alimentary Pharmacology & Therapeutics.

High carbohydrate consumption, obesity and depression are among the key risk factors associated with chronic diarrhea in a recent study of a nationally representative cohort published in the American Journal of Gastroenterology. Women and non-white individuals were also found to be at higher risk for the condition.

Patients with chronic pain suffering from opioid-induced constipation, or OIC, report they often experience delayed diagnosis, and are largely unsatisfied with treatment for their constipation, according to national survey results reported by Salix Pharmaceuticals.

Shire announced that the FDA has accepted a new drug application for prucalopride for the treatment of adults with chronic idiopathic constipation, according to a press release.

A meta-analysis published in Clinical Gastroenterology and Hepatology showed that mu-opioid receptor antagonists were safe and effective for treating opioid-induced constipation.

A prospective study of middle-aged and elderly twins in Denmark showed no association between long-term use of proton pump inhibitors and cognitive decline.